Table 2.
Author (Year) | Number of Participants | Age (Years) | OSA Severity Criteria | Outcomes | Results |
---|---|---|---|---|---|
Behavioral and neurocognitive sphere | |||||
Menzies et al., 2022 [38] Metanalysis of 63 studies |
17,834 | From 2 to 18 years | Due to the lack of a consensus severity criterion, the subgroup given by the author was used (e.g., mild OSA) | Intelligence, attention, memory, visual spatial skills, and language | Children with SDB had significant impairments in all cognitive domains, intelligence being the most-affected quality. These neurocognitive deficits were found in primary snorers among OSA children. |
Growth retardation and metabolism | |||||
Lagravère et al., 2019 [39] Systematic review of 12 studies |
Growth mediators (IGF-I and IGFBP-3) | Children with OSA present lower levels of growth mediators, indicating growth retardation, significantly higher cardiovascular disease risk, and decreased cognitive functions compared to healthy controls. Tonsillectomy may improve all these functions with a great impact on general health. |
|||
Cardiovascular sphere | |||||
Ai et al., 2022 [40] Metanalysis of 14 studies |
3081 | 3 to 17 years | Mild OSA is defined as an AHI between 1 and 5 events per hour Moderate to severe is defined as an AHI ≥ 5 /h. |
BP parameters: awake and nighttime SBP and DBP | The mean SBP was higher in children with mild or moderate-to-severe OSA compared to healthy controls, these effects being more pronounced during the night. The results suggest that moderate-to-severe OSA in children is associated with a higher risk of adverse SBP outcomes. |
Abbreviations: OSA: obstructive sleep apnea; SDB: sleep-disordered breathing; IGF-1: insulin-like growth factor 1; IGFBP3: insulin-like growth factor-binding protein 3; AHI: apnea/hypopnea index; BP: blood pressure; SBP: systolic blood pressure; DBP: diastolic blood pressure.